In contrast with a long list of over 70 medical research articles on low T3 syndrome that excluded thyroid patients, I have only found three (3) studies so far that included patients being treated for hypothyroidism. I’ll reveal their treasures… Read More ›
Here, I’ll use my own personal example to discuss a few dimensions of T3 monotherapy, which I envision as a “wheelchair.” I’m drawing on the fictional analogy I developed in an earlier post, where I imagined thyroid disease like crippling… Read More ›
Most studies of Low T3 syndrome (NTIS) routinely EXCLUDE thyroid patients. Sadly, our exclusion has become a research tradition. In this post, I lay out the landscape and extent of our exclusion from this valuable area of thyroid hormone health… Read More ›
In 2018, Ataoglu and colleagues confirmed and expanded our knowledge of “Low T3 syndrome.” Despite a normalized TSH, a Low T3 is deadly not only in acute, critical illness, but in “chronic disease.” To be specific, Low T3 is more… Read More ›
Seeing things visually might help clarify what thyroid therapy is like. Our thyroid hides in our neck and our hormones hide in every inch of our body. Nobody sees our thyroid gland distort, die, or shrivel. Nobody sees what fatigue… Read More ›
When you are steeped in a medical paradigm, its fallacies can be as comfortable and taken for granted as an old pair of sneakers. In this post, I’ll take apart several thyroid therapy fallacies, starting with the fallacy “description is… Read More ›
A 2017 article reported research on 11,806 healthy controls and 3,934 thyroidless people treated with L-T4 monotherapy in Sicily, and then did a more in-depth “retrospective longitudinal” study on 119 of the thyroid patients compared to 156 matched controls. They… Read More ›